连续获得临床批件!国内间充质干细胞治疗疾病将走向大众
干细胞之家—中国干细胞行业门户第一站
重要声明:“干细胞”公众号是干细胞之家网站唯一官方微信公众平台,其它任何带有“干细胞之家”字样的公众号皆为仿冒。
注意!近期有人以仿冒的干细胞之家网站工作人员身份在行业内进行诈骗活动,提醒大家谨防上当受骗。
作者:清华大学 晨光
专家审核:江苏大学附属医院 李晶 教授
1
间充干细胞治疗感染性肺部疾病
2
间充质干细胞治疗慢性肺部疾病
3
利用间充质干细胞治疗间质性肺病
4
利用间充质干细胞治疗肺部肿瘤
参考文献:
【1】 Majolo, F., da Silva, G.L., Vieira, L., Timmers, L.F.S.M., Laufer, S., and Goettert, M.I. (2020). Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19. Stem Cell Reviews and Reports 17, 44-55. 10.1007/s12015-020-10033-6.
https://pubmed.ncbi.nlm.nih.gov/32827081/
【2】 Yilmaz G, Vital S, Yilmaz CE, et al. Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature. Stroke, 2011, 42(3): 806-811.
https://pubmed.ncbi.nlm.nih.gov/21257828/
【3】 Hung SC, Pochampally RR, Chen SC, et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis,increase survival, and stimulate angiogenesis. Stem Cells, 2007,25(9): 2363-2370
https://pubmed.ncbi.nlm.nih.gov/17540857/
【4】 Averyanov A, Koroleva I, Konoplyannikov M, Revkova V, Lesnyak V, Kalsin V, Danilevskaya O, Nikitin A, Sotnikova A, Kotova S, Baklaushev V. First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med. 2020 Jan;9(1):6-16.
https://pubmed.ncbi.nlm.nih.gov/31613055/
【5】 Yang, S., Liu, P., Jiang, Y., Wang, Z., Dai, H., and Wang, C. (2021). Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis. Front Cell Dev Biol 9, 639657. 10.3389/fcell.2021.639657.
https://pubmed.ncbi.nlm.nih.gov/33768094/
【6】 SHA Y XIE Y,CHEN Z J,Interference research of umbilical cord mesenchymal stem cells on the pulmonary fibrosis in silicosis rats[J]. Chin J Ind Hyg Occup Dis,2019,37(6):401-407.
https://pubmed.ncbi.nlm.nih.gov/31256519/
【7】 AN G L, LI X L, WANG Y, et al. Assessment of antagonistic effect of bone marrow mesenchymal stem cells on pulmonary fibrosis in silicosis rat model by Micro CT[J]. J Cap Med Univ,2017,38(2):238-243.
https://pubmed.ncbi.nlm.nih.gov/30514375/
【8】 CHEN S, CUI G, PENG C, et al. Transplantation of adiposederived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats[J]. Stem Cell Res Ther,2018,9(1):110.
https://pubmed.ncbi.nlm.nih.gov/29673394/
【9】 Wu, H., Mu, X., Liu, L., Wu, H., Hu, X., Chen, L., Liu, J., Mu, Y., Yuan, F., Liu, W., and Zhao, Y. (2020). Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1. Cell Death Dis 11, 801. 10.1038/s41419-020-02962-4.
https://pubmed.ncbi.nlm.nih.gov/32978367/